Wang Y, Jain P, Locke FL, Maurer MJ, et al. Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. J Clin Oncol 2023 Feb 8:JCO2201797. doi: 10.1200/JCO.22.01797.
PMID: 36753699